• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Incidence and prevalence of dementia among US Medicare beneficiaries between 2015 – 2021

byJayden BerdugoandAlex Chan
May 31, 2025
in Chronic Disease, Neurology, Public Health
Reading Time: 2 mins read
Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer
Share on FacebookShare on TwitterShare on LinkedIn

1. In this cohort of older adults, the overall incidence of dementia decreased from 2015 to 2021, however, the prevalence increased. 

Evidence Rating Level: 2 (Good) 

Dementia has become a top priority in the United States due to the rapidly aging population. Dementia is a group of neurological conditions characterized by a decline in cognitive function that interferes with daily life. The burden of disease disproportionately impacts marginalized communities, specifically Black Americans and those with a lower socioeconomic status. This study aimed to assess how dementia rates vary by sex, race, and neighborhood deprivation using Medicare data, to inform future policies. To best achieve this, a retrospective population-based cohort study was conducted using Medicare claims data from 2013 to 2021 to analyze dementia rates in older adults. Researchers included only those enrolled in traditional fee-for-service Medicare, excluding those with private health plans. The primary outcomes were the rates of dementia incidence and prevalence adjusted for age and sex. Between 2015 to 2021, there were 5,025,039 new cases of dementia reported. The number of cases decreased from 838,824 to 628,902, with age and sex-adjusted incidence rates decreasing from 3.5% to 2.8%. During this same period, prevalence increased, reaching the highest point in 2019 with 3,140,758 cases before slightly declining to 2,875,718 by 2021, corresponding to an increase from 10.5% to 11.8%. In 2015, men had a statistically significantly higher rate of dementia than women (3.5% vs. 3.4%). By 2021, the difference had grown further (2.9% vs. 2.6%; estimated difference-in-difference 0.94, 95% confidence interval (CI) 0.94 to 0.95; P<0.001). In 2015, the highest age- and sex-adjusted incidence rates of dementia were in black beneficiaries (4.2%, 95% CI 4.2% to 4.2%), followed by Hispanic beneficiaries (3.7%, 3.6% to 3.7%), and non-Hispanic white beneficiaries (3.4%, 3.4% to 3.5%). In 2021, black beneficiaries still had the highest incidence (3.1%), followed by non-Hispanic white beneficiaries (2.8%) and then Hispanic beneficiaries (2.6%). The gap in dementia rates between white beneficiaries and other racial and ethnic groups decreased significantly between 2015 and 2021 (estimated difference-in-difference 0.92 (95% CI 0.91 to 0.93) compared with black beneficiaries, 0.88 (0.87 to 0.89) compared with Hispanic beneficiaries). In this retrospective cohort study from 2015 to 2021, the incidence of dementia decreased, however, the prevalence significantly increased, indicating that by 2021, approximately 2.9 Medicare beneficiaries likely had a dementia diagnosis. 

Click to read the study in BMJ

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

2 Minute Medicine Rewind October 12, 2026

Tags: dementiageriatric medicineneurologyneuropsychiatrypublic health
Previous Post

Personalized visual perceptual learning digital therapy may improve vision post-stroke

Next Post

Mixed reality exposure therapy may have a role in obsessive-compulsive disorder

RelatedReports

A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 17, 2026
An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
A senior woman looks thoughtfully at a balance scale with a stethoscope and a heart illustration, symbolizing the assessment of cardiovascular risk and treatment decisions.
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Next Post
Patient care collage: a calm older woman with silver hair beside a steel tray with a penlight and reflex hammer, and a fern

Mixed reality exposure therapy may have a role in obsessive-compulsive disorder

#VisualAbstract: As-Needed Albuterol-Budesonide is Effective in Mild Asthma

#VisualAbstract: As-Needed Albuterol-Budesonide is Effective in Mild Asthma

#VisualAbstract: Navigational Bronchoscopy is Noninferior to Transthoracic Needle Biopsy for Diagnostic Accuracy in Lung Nodules

#VisualAbstract: Navigational Bronchoscopy is Noninferior to Transthoracic Needle Biopsy for Diagnostic Accuracy in Lung Nodules

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.